{"nct_id":"NCT01939158","title":"Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine","status":"COMPLETED","status_verified_date":"2021-09","start_date":"2013-10-02","start_date_type":"ACTUAL","primary_completion_date":"2019-12-05","primary_completion_date_type":"ACTUAL","completion_date":"2019-12-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}